Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sili Wang

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Physiology|January 8, 2024
Frontiers and hotspots of adipose tissue and NAFLD: a bibliometric analysis from 2002 to 2022Shuxiao Gu, Yanfang Qiao, Susu Liu, et al.
Chemical Science|April 29, 2017
Enrichment and single-cell analysis of circulating tumor cellsYanling Song, Tian Tian, Yuanzhi Shi, et al.
International Journal of Hematology|October 7, 2005
Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese populationXuwei Hou, Sili Wang, Yuling Zhou, et al.
Cardiovascular Drugs and Therapy|October 10, 2007
Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathyXing Chen, Yongli Chen, Yanyong Bi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 14, 2016
[Clinical features and risk factors for infections in adult acute leukemia after chemotherapy]Yiming Luo, Tingbo Liu, Siting Xie, et al.
Journal of Ethnopharmacology|April 30, 2026
Oroxin A in Linggui Zhugan Decoction in the treatment of MASH by regulating cholesterol-bile acid metabolismPan Gao, Sili Wang, Mingjiao Jia, et al.
Nature Communications|June 17, 2025
A continental scale analysis reveals widespread root bimodalityMingzhen Lu, Sili Wang, Avni Malhotra, et al.
BMC Cancer|November 13, 2024
Prediction model of male reproductive function damage caused by CHOP chemotherapy regimen for non-Hodgkin's lymphomaJiabao Zhang, Aili Zhang, Jiaxin Liu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 24, 2020
Highly Sensitive Minimal Residual Disease Detection by Biomimetic Multivalent Aptamer Nanoclimber Functionalized Microfluidic ChipYilong Liu, Huimin Zhang, Yahui Du, et al.
Annals of Hematology|September 6, 2020
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center studyJing Li, Li Bao, Zhongjun Xia, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Physiology|January 8, 2024
Frontiers and hotspots of adipose tissue and NAFLD: a bibliometric analysis from 2002 to 2022Shuxiao Gu, Yanfang Qiao, Susu Liu, et al.
Chemical Science|April 29, 2017
Enrichment and single-cell analysis of circulating tumor cellsYanling Song, Tian Tian, Yuanzhi Shi, et al.
International Journal of Hematology|October 7, 2005
Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese populationXuwei Hou, Sili Wang, Yuling Zhou, et al.
Cardiovascular Drugs and Therapy|October 10, 2007
Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathyXing Chen, Yongli Chen, Yanyong Bi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 14, 2016
[Clinical features and risk factors for infections in adult acute leukemia after chemotherapy]Yiming Luo, Tingbo Liu, Siting Xie, et al.
Journal of Ethnopharmacology|April 30, 2026
Oroxin A in Linggui Zhugan Decoction in the treatment of MASH by regulating cholesterol-bile acid metabolismPan Gao, Sili Wang, Mingjiao Jia, et al.
Nature Communications|June 17, 2025
A continental scale analysis reveals widespread root bimodalityMingzhen Lu, Sili Wang, Avni Malhotra, et al.
BMC Cancer|November 13, 2024
Prediction model of male reproductive function damage caused by CHOP chemotherapy regimen for non-Hodgkin's lymphomaJiabao Zhang, Aili Zhang, Jiaxin Liu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 24, 2020
Highly Sensitive Minimal Residual Disease Detection by Biomimetic Multivalent Aptamer Nanoclimber Functionalized Microfluidic ChipYilong Liu, Huimin Zhang, Yahui Du, et al.
Annals of Hematology|September 6, 2020
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center studyJing Li, Li Bao, Zhongjun Xia, et al.
Pageof 4